20(S)-Ginsenoside Rg3
CAS: 14197-60-5
Ref. TM-T3402
5mg | 38,00 € | ||
10mg | 56,00 € | ||
25mg | 84,00 € | ||
50mg | 95,00 € | ||
100mg | 167,00 € | ||
1ml*10 (DMSO) | 63,00 € |
- Angiogénesis
- Beta amiloide
- Inhibidores de ciclooxigenasa (COX)
- EGFR
- Inmunología e inflamación
- Inhibidores
- Señalización JAK / STAT
- Transportador de membrana / canal de iones
- Metabolismo
- NF-κB
- Neurociencia
- Señalización PI3K / Akt / mTOR
- Compuestos y metabolitos farmacéuticos y veterinarios
- Canal de potasio
- Canal de sodio
- Tirosina quinasa / adaptadores
Información del producto
- 20(S)-Ginsenoside-Rg3, Rg3, 20S-Ginsenoside Rg3, Ginsenoside Rg3, S-Ginsenoside Rg3
- (20S)-Propanaxadiol
- (2S,3R,4S,5S,6R)-2-[(2R,3R,4S,5S,6R)-4,5-dihydroxy-2-[[(10R,12S,13R,14R,17S)-12-hydroxy-17-[(2R)-2-hydroxy-6-methylhept-5-en-2-yl]-4,4,10,13,14-pentamethyl-2,3,5,6,7,8,9,11,12,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl]oxy]-6-(hydroxymethyl)oxa
- (3Beta,12Beta)-12,20-Dihydroxydammar-24-En-3-Yl 2-O-Beta-D-Glucopyranosyl-Beta-D-Glucopyranoside
- (3β,12β)-12,20-Dihydroxydammar-24-en-3-yl 2-O-β-<span class="text-smallcaps">D</smallcap>-glucopyranosyl-β-<smallcap>D</span>-glucopyranoside
- (3β,12β)-12,20-Dihydroxydammar-24-en-3-yl O-β-<span class="text-smallcaps">D</smallcap>-glucopyranosyl-(1→2)-β-<smallcap>D</span>-glucopyranoside
- (5xi,8xi,9xi,12alpha,14beta,20R)-12,20-dihydroxylanost-24-en-3-yl 2-O-beta-D-glucopyranosyl-beta-D-glucopyranoside
- (8xi,9xi,12alpha,14beta,17alpha)-12-hydroxy-17-[(2S)-2-hydroxy-6-methylhept-5-en-2-yl]-4,4,10,14-tetramethylgonan-3-yl 2-O-[3-deoxy-3-(hydroxymethyl)-beta-D-glucopyranosyl]-beta-D-glucopyranoside
- 20(R)-Propanaxadiol
- 20(S)-Ginsenoside-Rg3
- Ver más sinónimos
- 20(S)-Ginsenoside-Rg<sub>3</sub>
- 20(S)-Rg3
- 20S-Ginsenoside Rg3
- 3-O-β-<span class="text-smallcaps">D</smallcap>-Glucopyranosyl-(1→2)-β-<smallcap>D</span>-glucopyranosyldammar-24-ene-3β,12β,20S-triol
- Beta-D-Glucopyranoside,(3-Beta,12-Beta)-12,20-Dihydroxydammar-24-En-3-Yl2-O-B
- Dammar-24-Ene-12-Beta,20-Diol,3-Beta-((2-O-Beta-D-Glucopyranosyl-Beta-D-Gluc
- Dammar-24-ene-12β,20-diol, 3β-[(2-O-β-<span class="text-smallcaps">D</smallcap>-glucopyranosyl-β-<smallcap>D</span>-glucopyranosyl)oxy]-
- Dammar-24-ene-12β,20-diol, 3β-[(2-O-β-D-
- Dammarane, β-<span class="text-smallcaps">D</span>-glucopyranoside deriv.
- Eta-D-Glucopyranosyl-
- Ginsenoside 20-Rg3
- Ginsenoside Rg3s
- Ginsenoside Rg<sub>3</sub>
- Opyransoyl)Oxy)-
- S-Ginsenoside Rg<sub>3</sub>
- beta-D-Glucopyranoside,(3beta,12beta)-12,20-dihydroxydammar-24-en-3-yl 2-O-beta-D-glucopyranosyl
- β-<span class="text-smallcaps">D</smallcap>-Glucopyranoside, (3β,12β)-12,20-dihydroxydammar-24-en-3-yl 2-O-β-<smallcap>D</span>-glucopyranosyl-
20(S)-Ginsenoside Rg3 (Rg3) possess an ability to inhibit the lung metastasis of tumor cells via inhibition of the adhesion and invasion of tumor cells. It inhibits the proliferation of human umbilical vein endothelial cells(HUVEC) and has anti-angiogenesis activities.
Propiedades químicas
Consulta técnica sobre: TM-T3402 20(S)-Ginsenoside Rg3
Si desea solicitar un presupuesto o realizar un pedido, por favor añada los productos deseados a su carrito y solicite un presupuesto o pedido desde el carrito. Es más rápido, más barato, y podrá beneficiarse de los descuentos y las ventajas disponibles.